Dr. Joanna A. Cooper, MD

Dr. Cooper practices at Sutter East Bay Medical Foundation in Berkeley, California.

Dr. Cooper's NPI, 1558477018, was assigned on August 21, 2006. Dr. Cooper graduated from Tel Aviv University Sackler in 1975. Dr. Cooper holds California license A35454.

Dr. Cooper's primary practice is Sutter East Bay Medical Foundation, at 2850 Telegraph Ave Suite 110 Suite 110, Berkeley, CA 94705-1159. The practice phone is (510) 204-8110.

Dr. Cooper's primary practice is Sutter East Bay Medical Foundation in Berkeley, California. Dr. Cooper is also affiliated with Alta Bates Summit Medical Center | Alta Bates Campus. The medical group on file is Palo Alto Foundation Medical Group. Dmand AI also links Dr. Cooper to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cooper practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Cooper's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Cooper is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Cooper's licenses on file in 2 states: California and New York.

Dmand AI lists acute mini-stroke (TIA), carpal tunnel syndrome, cerebrovascular disease, epilepsy, fibromyalgia and chronic pain, hypersomnia, migraine and chronic headache and mobility impairment among the conditions Dr. Cooper treats.

CMS data shows 10,152 Medicare services from Dr. Cooper across 16 procedure codes in 2024, for 632 Medicare patients. Medicare paid $159,368 for them.

CMS counts 632 Medicare patients who saw Dr. Cooper in 2024. The largest group is 65 to 74, with 261 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 27% are also on Medicaid. Their average risk score is 1.45, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Cooper's median patient age at 59, with 48% women.

In 2024, Dr. Cooper wrote 1,148 Medicare Part D claims for 164 patients. 87% of them were for generic drugs. CMS names the drug for 854 of them, across 34 drugs with 11 or more claims each, at $218,099 in total drug cost. In 2023, CMS named 1,028 claims across 44 drugs.

Dr. Cooper accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cooper as offering telehealth.

Dmand AI links 16 papers to Dr. Cooper, published from 2006 to 2023. The most frequent topics are Multiple Sclerosis, Cognition Disorders and Frontal Lobe. Dr. Cooper has published most often in Ann Neurol. Dr. Cooper's most frequent co-authors are Revere Philip Kinkel, MD, Robert Thomas Knight, MD and Kristen Marie Krysko, MD.

Dmand AI links Dr. Cooper to 4 clinical trials, 2 of them phase 2 studies. Conditions studied include Multiple Sclerosis, Demyelinating Autoimmune Diseases, CNS and Multiple Sclerosis, Chronic Progressive.

CMS Open Payments shows 148 general payments to Dr. Cooper from 29 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 71% of the total. Novartis Pharmaceuticals Corporation paid the most, $2,452. It also lists 1 research payment totaling $51 in 2017.

Dmand AI lists 3 awards for Dr. Cooper, most recently CMS Stage 1 EHR in 2013.

Dr. Cooper graduated from Tel Aviv University Sackler in 1975.

Dr. Cooper is in network with 11 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.